| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-14 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.28 | 3e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |